Menu

The Role of SRSF3 in mRNA Splicing and Cellular Regulation: A Key Player in Health and Disease

Endocrinology Diagnostics

Introduction and Its Functional Significance

  • SRSF3 (Serine and Arginine Rich Splicing Factor 3) belongs to the SR protein family.
  • Involved in alternative splicing and mRNA processing.
  • Impacts post-transcriptional gene regulation, cell cycle control, and cell differentiation.
  • Recent research highlights its roles in growth, cancer, and cellular stress responses.

Molecular Mechanisms and Role in Alternative Splicing

  • Splicing enables a gene to create various proteins, heavily reliant on SR proteins like SRSF3.
  • SRSF3 binds to exonic splicing enhancers (ESEs) and recruits spliceosome components.
  • Determines inclusion or exclusion of exons in mRNA transcripts.
  • Vital in tissues like heart and nerve cells for splicing gene functions.
  • Plays a role in stress responses, making splicing decisions for repair or cell death.

Development and Differentiation

  • Influences growth and specialization of cells during development.
  • Levels fluctuate with cell progression stages; higher in rapidly dividing cells.
  • In embryos, influences pluripotency gene expression for stem cell formation.
  • In cell differentiation, blocks pathways for specialization, maintaining growth state.
  • Has implications in regenerative medicine and developmental biology.

Role in Cancer and Disease

  • Increased presence in cancer types like liver, lung, and breast cancers.
  • Influences splicing of oncogenes and tumor suppressors, promoting survival and proliferation.
  • In liver cancer, promotes glycolytic function for growth and survival.
  • Adjusts splicing of apoptosis-related genes to prevent cell death and promote tumors.
  • Linked with Alzheimer's disease, heart conditions, and structural protein splicing.

Therapeutic Potential and Future Directions

  • Potential target for treating splicing irregularities in diseases.
  • Research on chemical compounds to influence splicing by targeting SRSF3.
  • RNA-based treatments like antisense oligonucleotides (ASOs) for correcting splicing abnormalities.
  • ASOs tailored to target molecules improperly regulated by SRSF3.
  • Ongoing clinical studies for ASOs aiming at splicing regulators.
  • Understanding SRSF3 functions in cell metabolism and stress response for new treatment options.
ENQUIRY FORM

More News

  • TNF Alpha: A Central Mediator of Inflammation and Immune Response

  • Sclerostin (SOST): The Master Regulator of Bone Formation

  • TNFSF11/RANKL: A Key Regulator of Bone Metabolism and Beyond

  • Superoxide Dismutase (SOD): The Body's Powerful Antioxidant Defence System